1
|
Gottlieb S, Rand JS, Ishioka K, Dias DA, Boughton BA, Roessner U, Ramadan Z, Anderson ST. Measures of insulin sensitivity, leptin, and adiponectin concentrations in cats in diabetic remission compared to healthy control cats. Front Vet Sci 2022; 9:905929. [PMID: 35968003 PMCID: PMC9372504 DOI: 10.3389/fvets.2022.905929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 07/04/2022] [Indexed: 12/03/2022] Open
Abstract
Objectives Firstly, to compare differences in insulin, adiponectin, leptin, and measures of insulin sensitivity between diabetic cats in remission and healthy control cats, and determine whether these are predictors of diabetic relapse. Secondly, to determine if these hormones are associated with serum metabolites known to differ between groups. Thirdly, if any of the hormonal or identified metabolites are associated with measures of insulin sensitivity. Animals Twenty cats in diabetic remission for a median of 101 days, and 21 healthy matched control cats. Methods A casual blood glucose measured on admission to the clinic. Following a 24 h fast, a fasted blood glucose was measured, and blood sample taken for hormone (i.e., insulin, leptin, and adiponectin) and untargeted metabolomic (GC-MS and LC-MS) analysis. A simplified IVGGT (1 g glucose/kg) was performed 3 h later. Cats were monitored for diabetes relapse for at least 9 months (270 days). Results Cats in diabetic remission had significantly higher serum glucose and insulin concentrations, and decreased insulin sensitivity as indicated by an increase in HOMA and decrease in QUICKI and Bennett indices. Leptin was significantly increased, but there was no difference in adiponectin (or body condition score). Several significant correlations were found between insulin sensitivity indices, leptin, and serum metabolites identified as significantly different between remission and control cats. No metabolites were significantly correlated with adiponectin. No predictors of relapse were identified in this study. Conclusion and clinical importance Insulin resistance, an underlying factor in diabetic cats, persists in diabetic remission. Cats in remission should be managed to avoid further exacerbating insulin resistance.
Collapse
Affiliation(s)
- Susan Gottlieb
- The Cat Clinic, Brisbane, QLD, Australia
- School of Veterinary Science, The University of Queensland, Gatton, QLD, Australia
- *Correspondence: Susan Gottlieb
| | - Jacquie S. Rand
- School of Veterinary Science, The University of Queensland, Gatton, QLD, Australia
- Australian Pet Welfare Foundation, Kenmore, QLD, Australia
| | - Katsumi Ishioka
- School of Veterinary Nursing and Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - Daniel A. Dias
- Discipline of Laboratory Medicine, School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT) University, Bundoora, VIC, Australia
| | - Berin A. Boughton
- School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia
- Australian National Phenome Centre, Murdoch University, Murdoch, WA, Australia
| | - Ute Roessner
- School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia
| | - Ziad Ramadan
- Nestlé Purina Research, St Louis, MO, United States
| | - Stephen T. Anderson
- School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia
| |
Collapse
|
2
|
Gottlieb S, Rand J, Anderson ST, Morton JM, Dias DA, Boughton BA, Roessner U, Ramadan Z. Metabolic Profiling of Diabetic Cats in Remission. Front Vet Sci 2020; 7:218. [PMID: 32500084 PMCID: PMC7242727 DOI: 10.3389/fvets.2020.00218] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 04/01/2020] [Indexed: 12/25/2022] Open
Abstract
Background: The majority of diabetic cats in remission have abnormal glucose tolerance, and approximately one third relapse within 1 year. Greater understanding of the metabolic characteristics of diabetic cats in remission, and predictors of relapse is required to effectively monitor and manage these cats. Objectives: To identify and compare differences in plasma metabolites between diabetic cats in remission and healthy control cats using a metabolomics approach. Secondly, to assess whether identified metabolites are predictors of diabetic relapse. Animals: Twenty cats in diabetic remission for a median of 101 days, and 22 healthy matched control cats. Methods: Cats were admitted to a clinic, and casual blood glucose was recorded. After a 24 h fast, blood glucose concentration was measured, then a blood sample was taken for metabolomic (GCMS and LCMS) analyses. Three hours later, a simplified intravenous glucose tolerance test (1 g glucose/kg) was performed. Cats were monitored for diabetes relapse for at least 9 months (270 days) after baseline testing. Results: Most cats in remission continued to display impaired glucose tolerance. Concentrations of 16 identified metabolites differed (P ≤ 0.05) between remission and control cats: 10 amino acids and stearic acid (all lower in remission cats), and glucose, glycine, xylitol, urea and carnitine (all higher in remission cats). Moderately close correlations were found between these 16 metabolites and variables assessing glycaemic responses (most |r| = 0.31 to 0.69). Five cats in remission relapsed during the study period. No metabolite was identified as a predictor of relapse. Conclusion and clinical importance: This study shows that cats in diabetic remission have abnormal metabolism.
Collapse
Affiliation(s)
- Susan Gottlieb
- The Cat Clinic, Brisbane, QLD, Australia.,School of Veterinary Science, The University of Queensland, Gatton, QLD, Australia
| | - Jacquie Rand
- School of Veterinary Science, The University of Queensland, Gatton, QLD, Australia.,Australian Pet Welfare Foundation, Kenmore, QLD, Australia
| | - Stephen T Anderson
- School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, Australia
| | - John Murray Morton
- School of Veterinary Science, The University of Queensland, Gatton, QLD, Australia.,Jemora Pty Ltd, Geelong, VIC, Australia
| | - Daniel A Dias
- School of Health and Biomedical Sciences, Discipline of Laboratory Medicine, RMIT University, Bundoora, VIC, Australia
| | - Berin A Boughton
- Metabolomics Australia, School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia
| | - Ute Roessner
- Metabolomics Australia, School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia
| | - Ziad Ramadan
- Nestlé Purina Research, St. Louis, MO, United States
| |
Collapse
|
3
|
Abstract
Many owners are able and willing to perform home monitoring of blood glucose concentrations in diabetic cats. Once owners are familiar with the technique, they appreciate its advantages and show long-term compliance. The success of home monitoring hinges greatly on careful preparation and instruction of the owner. Owners must have ready access to veterinary support if needed. Initially, most owners call for advice, and several of them need repeated explanation or demonstration of the procedure. The frequency of re-evaluations of the diabetic cats by veterinarians is not affected by home monitoring. One of its major advantages is that it enables frequent generation of blood glucose curves. In complicated cases, more than one curve can, therefore, be performed at home before a treatment decision is made. According to preliminary data cats managed with home monitoring may have better glycaemic control than those managed without. However, those results need to be confirmed in a large group of cats.
Collapse
Affiliation(s)
- Claudia E Reusch
- Clinic for Small Animal Internal Medicine, Vetsuisse-Faculty University of Zurich, Switzerland.
| | | | | |
Collapse
|
4
|
Casella M, Hässig M, Reusch CE. Home-monitoring of blood glucose in cats with diabetes mellitus: Evaluation over a 4-month period. J Feline Med Surg 2016; 7:163-71. [PMID: 15922223 DOI: 10.1016/j.jfms.2004.08.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2004] [Accepted: 08/31/2004] [Indexed: 11/28/2022]
Abstract
Home-monitoring of blood glucose concentrations has recently been introduced to owners. The objectives of this study were to investigate the feasibility of home-monitoring of blood glucose in diabetic cats by owners, the problems encountered and to compare glucose concentrations at home with those measured in the hospital. Twelve of 15 cat owners were able to generate glucose curves over the study period of 4 months. Most problems were related to restraining the cat, generating negative pressure with the lancing device and producing a blood drop. In the majority of cases, these problems could be resolved during the study. Blood glucose concentrations in the clinic tended to be lower than at home; some of the differences were significant. No association between tolerance of the procedure and blood glucose concentrations measured at home was found. We, therefore, assume that the lower glucose levels in the hospital were caused by lack of food intake. In 38% of cases, treatment based on hospital curves would have been different from that based on home curves. Home-monitoring appears to be a valuable tool in the management of cats with diabetes mellitus. One of its major advantages is that it enables frequent generation of blood glucose curves, which is of particular importance in cats that are difficult to regulate.
Collapse
Affiliation(s)
- Martina Casella
- Clinic for Small Animal Internal Medicine, Vetsuisse-Faculty University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland
| | | | | |
Collapse
|
5
|
Reeve-Johnson MK, Rand JS, Anderson ST, Appleton DJ, Morton JM, Vankan D. Dosing obese cats based on body weight spuriously affects some measures of glucose tolerance. Domest Anim Endocrinol 2016; 57:133-42. [PMID: 27572923 DOI: 10.1016/j.domaniend.2016.05.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/19/2015] [Revised: 05/18/2016] [Accepted: 05/19/2016] [Indexed: 10/21/2022]
Abstract
The primary objective was to investigate whether dosing glucose by body weight results in spurious effects on measures of glucose tolerance in obese cats because volume of distribution does not increase linearly with body weight. Healthy research cats (n = 16; 6 castrated males, 10 spayed females) were used. A retrospective study was performed using glucose concentration data from glucose tolerance and insulin sensitivity tests before and after cats were fed ad libitum for 9 to 12 mo to promote weight gain. The higher dose of glucose (0.5 vs 0.3 g/kg body weight) in the glucose tolerance tests increased 2-min glucose concentrations (P < 0.001), and there was a positive correlation between 2-min and 2-h glucose (r = 0.65, P = 0.006). Two-min (P = 0.016 and 0.019, respectively), and 2-h (P = 0.057 and 0.003, respectively) glucose concentrations, and glucose half-life (T1/2; P = 0.034 and <0.001 respectively) were positively associated with body weight and body condition score. Glucose dose should be decreased by 0.05 g for every kg above ideal body weight. Alternatively, for every unit of body condition score above 5 on a 9-point scale, observed 2-h glucose concentration should be adjusted down by 0.1 mmol/L. Dosing glucose based on body weight spuriously increases glucose concentrations at 2 h in obese cats and could lead to cats being incorrectly classified as having impaired glucose tolerance. This has important implications for clinical studies assessing the effect of interventions on glucose tolerance when lean and obese cats are compared.
Collapse
Affiliation(s)
- M K Reeve-Johnson
- School of Veterinary Science, The University of Queensland, QLD, Australia.
| | - J S Rand
- School of Veterinary Science, The University of Queensland, QLD, Australia
| | - S T Anderson
- Biomedical Science, The University of Queensland, QLD, Australia
| | - D J Appleton
- Hill's Pet Nutrition Pty Ltd., P O Box 1003, North Ryde, NSW 1670 Australia
| | - J M Morton
- School of Veterinary Science, The University of Queensland, QLD, Australia
| | - D Vankan
- School of Veterinary Science, The University of Queensland, QLD, Australia
| |
Collapse
|
6
|
Comparative Aspects of Human, Canine, and Feline Obesity and Factors Predicting Progression to Diabetes. Vet Sci 2014. [DOI: 10.3390/vetsci1020121] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
|
7
|
Farrow HA, Rand JS, Morton JM, O'Leary CA, Sunvold GD. Effect of dietary carbohydrate, fat, and protein on postprandial glycemia and energy intake in cats. J Vet Intern Med 2013; 27:1121-35. [PMID: 23869495 DOI: 10.1111/jvim.12139] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2012] [Revised: 03/13/2013] [Accepted: 05/29/2013] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Reducing carbohydrate intake is recommended in diabetic cats and might also be useful in some healthy cats to decrease diabetes risk. OBJECTIVE To compare postprandial glucose and insulin concentrations and energy intakes between cats fed diets high in protein, fat, or carbohydrate. ANIMALS Twenty-four lean cats with normal glucose tolerance. METHODS In a prospective randomized study, each of 3 matched groups (n = 8) received a different test diet for 5 weeks. Diets were high in either protein (46% of metabolizable energy [ME]), fat (47% ME), or carbohydrate (47% ME). Glucose and insulin were measured during glucose tolerance, ad libitum, and meal-feeding tests. RESULTS During ad libitum feeding, cats fed the high-carbohydrate diet consumed 25% and 18% more carbohydrate than cats fed diets high in fat and protein, respectively, and energy intake was highest when the high-fat and high-protein diets were fed. Regardless of the feeding pattern, cats fed the high-carbohydrate diet had 10-31% higher peak and mean glucose compared with both other diets; peak glucose in some cats reached 10.4 mmol/L (188 mg/dL) in cats fed 47% ME carbohydrate and 9.0 mmol/L (162 mg/dL) in cats fed 23% ME. CONCLUSIONS AND CLINICAL IMPORTANCE High-carbohydrate diets increase postprandial glycemia in healthy cats compared with diets high in fat or protein, although energy intake is lower. Avoidance of high- and moderate-carbohydrate diets can be advantageous in cats at risk of diabetes. Maintenance energy requirements should be fed to prevent weight gain when switching to lower carbohydrate diets.
Collapse
Affiliation(s)
- H A Farrow
- School of Veterinary Science, The University of Queensland, Brisbane, Qld, Australia
| | | | | | | | | |
Collapse
|
8
|
Link KRJ, Allio I, Rand JS, Eppler E. The effect of experimentally induced chronic hyperglycaemia on serum and pancreatic insulin, pancreatic islet IGF-I and plasma and urinary ketones in the domestic cat (Felis felis). Gen Comp Endocrinol 2013; 188:269-81. [PMID: 23660449 DOI: 10.1016/j.ygcen.2013.04.029] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/26/2013] [Revised: 04/17/2013] [Accepted: 04/19/2013] [Indexed: 01/01/2023]
Abstract
Like in humans, diabetes mellitus is on the rise in cats. Feline diabetes is a suitable model for human type-2 diabetes. We investigated magnitude and timing of insulin suppression with induced hyperglycaemia and its relationship to plasma and urinary ketones and to pancreatic islet insulin. IGF-I is under discussion as a protective mechanism but little is known about its role in diabetes in general and its distinct localisation in feline pancreatic islets in particular. Thirteen healthy, adult cats were allocated to 2 groups and infused with glucose to maintain their blood glucose at a high or moderate concentration for 42 days resulting in insulin secretion suppression. After initial increase, insulin levels declined to baseline but were still detectable in the blood at a very low level after 6 weeks of glucose infusion and then increased after a 3 week recovery period. While IGF-I in healthy cats was primarily located in glucagon cells, in hyperglycaemia-challenge IGF-I was pronounced in the β-cells 3 weeks after ceasation of infusion. Six/8 cats developing glucose toxicity became ketonuric after 3-4 weeks. Gross lipaemia occurred approx 1 week prior to ketonuria. Ketonuric cats required 1-2 weeks of insulin therapy after-infusion until β-cell recovery. In conclusion, ketosis and hyperlipidaemia are likely to occur in diabetic cats with glucose at 30 mmol/L, especially after ≥2 weeks. Three weeks after ceasation of infusions, clinical and morphological recovery occurred. We propose a local protective effect of IGF-I to support survival and insulin production in the hyperglycaemic state and recovery period.
Collapse
Affiliation(s)
- Karl R J Link
- Centre for Evolutionary Medicine (ZEM), Institute of Anatomy, University of Zurich, Zurich, Switzerland
| | | | | | | |
Collapse
|
9
|
Lowe AD, Graves TK, Campbell KL, Schaeffer DJ. A Pilot Study Comparing the Diabetogenic Effects of Dexamethasone and Prednisolone in Cats. J Am Anim Hosp Assoc 2009; 45:215-24. [DOI: 10.5326/0450215] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Fourteen cats received either daily prednisolone (4.4 mg/kg per os [PO]) or dexamethasone (0.55 mg/kg PO) for 56 days. These doses were clinically equipotent. Serum fructosamine and urine glucose were measured on days 0, 28, and 56. Insulin sensitivity, glucose tolerance, and peak insulin secretion were measured in each group prior to and at the end of the courses of glucocorticoid administration. On day 56, the prevalence of glucosuria was significantly greater (P=0.027), and a trend was seen toward greater fructosamine concentrations (P=0.083) in dexamethasone-treated cats compared to prednisolone-treated cats. The results of this pilot study also showed a trend toward a greater decrease in insulin sensitivity (P=0.061) and a significantly lower compensatory increase in insulin secretion (P=0.081) in the dexamethasone-treated cats than in cats administered prednisolone. These preliminary data suggest that dexamethasone exhibits greater diabetogenic effects in cats than equipotent doses of prednisolone. Further study is justified to support this hypothesis.
Collapse
Affiliation(s)
- Andrew D. Lowe
- Departments of Veterinary Clinical Medicine (Lowe, Graves, Campbell) and Veterinary Biosciences (Schaeffer), University of Illinois, 1008 West Hazelwood Drive, Urbana, Illinois 61834
- From the
| | - Thomas K. Graves
- Departments of Veterinary Clinical Medicine (Lowe, Graves, Campbell) and Veterinary Biosciences (Schaeffer), University of Illinois, 1008 West Hazelwood Drive, Urbana, Illinois 61834
- From the
| | - Karen L. Campbell
- Departments of Veterinary Clinical Medicine (Lowe, Graves, Campbell) and Veterinary Biosciences (Schaeffer), University of Illinois, 1008 West Hazelwood Drive, Urbana, Illinois 61834
- From the
| | - David J. Schaeffer
- Departments of Veterinary Clinical Medicine (Lowe, Graves, Campbell) and Veterinary Biosciences (Schaeffer), University of Illinois, 1008 West Hazelwood Drive, Urbana, Illinois 61834
- From the
| |
Collapse
|
10
|
Link KR, Rand JS. Changes in blood glucose concentration are associated with relatively rapid changes in circulating fructosamine concentrations in cats. J Feline Med Surg 2008; 10:583-92. [PMID: 18990597 DOI: 10.1016/j.jfms.2008.08.005] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/27/2008] [Indexed: 10/21/2022]
Abstract
The aim of the study was to determine the time required for plasma fructosamine concentration to increase after the onset of hyperglycaemia and decrease after resolution of hyperglycaemia. Healthy cats (n=14) were infused to maintain either moderate hyperglycaemia (n=5) (actual mean glucose 17 mmol/l) or marked hyperglycaemia (n=9) (actual 29 mmol/l) for 42 days. Fructosamine exceeded the upper limit of the reference range (331 micromol/l) after 3-5 days of marked hyperglycaemia, took 20 days to plateau and, after cessation of infusion, took 5 days to return to baseline. Fructosamine concentration for moderate hyperglycaemia took longer to exceed the reference range (7 days, range 4-14 days), and fewer days to plateau (8 days) and return to baseline (1 day). In cats with moderate hyperglycaemia, fructosamine concentration mostly fluctuated under the upper limit of the reference range. The range of fructosamine concentrations associated with a given glucose concentration was wide. The critical difference for fructosamine was 33 micromol/l.
Collapse
Affiliation(s)
- Karl R Link
- Centre for Companion Animal Health, School of Veterinary Science, University of Queensland, Queensland 4072, Australia.
| | | |
Collapse
|
11
|
Kurihara H, Yao XS, Nagai H, Tsuruoka N, Shibata H, Kiso Y, Fukami H. Anti-Stress Effect of BRAND'S Essence of Chicken (BEC) on Plasma Glucose Levels in Mice Loaded with Restraint Stress. ACTA ACUST UNITED AC 2006. [DOI: 10.1248/jhs.52.252] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Hiroshi Kurihara
- Institute of Traditional Chinese Medicine and Natural Products, Jinan University
| | - Xin-Sheng Yao
- Institute of Traditional Chinese Medicine and Natural Products, Jinan University
| | - Hajime Nagai
- BRAND'S Centre for Health and Nutritional Sciences, Cerebos Pacific Ltd
| | - Nobuo Tsuruoka
- Institute for Health Care Science, Research Center, Suntory Ltd
| | - Hiroshi Shibata
- Institute for Health Care Science, Research Center, Suntory Ltd
| | - Yoshinobu Kiso
- Institute for Health Care Science, Research Center, Suntory Ltd
| | - Harukazu Fukami
- Department of Bioscience and Biotechnology, Faculty of Bioenviromental Science, Kyotogakuen University
| |
Collapse
|
12
|
Wiedmeyer CE, Johnson PJ, Cohn LA, Meadows RL, Kerl ME, Tessman RK, Perlis J, DeClue AE. Evaluation of a continuous glucose monitoring system for use in veterinary medicine. Diabetes Technol Ther 2005; 7:885-95. [PMID: 16386094 DOI: 10.1089/dia.2005.7.885] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
BACKGROUND With the emergence of continuous glucose monitoring systems being used to provide a detailed glucose picture in humans, a commercially available system (CGMS(R), Medtronic Minimed, Northridge, CA) was examined for use in veterinary species. METHODS Adult, clinically normal horses (n = 7), cats (n = 3), dogs (n = 4), and cows (n = 5) were studied. Cats (n = 4), dogs (n = 5), and one horse with diabetes were included in the study. Several of the normal horses, including the horse with diabetes, and one cow were subjected to an intravenous glucose tolerance test. The CGMS was attached to each animal, and the recorded interstitial glucose concentrations were compared with whole blood glucose concentrations as determined by a point-of-care glucose meter. Events such as insulin administration, feeding, travel, or administration of intravenous glucose were all noted and compared with results from the CGMS. RESULTS There was a positive correlation between interstitial and whole blood glucose concentrations for all the clinically normal species, those with diabetes mellitus, and those receiving intravenous glucose. Events such as feeding, glucose or insulin administration, and transport to the clinic were noted by the owner or clinician and could be identified on the graph and correlated with time of occurrence. CONCLUSIONS Our data indicate that the use of the CGMS is valid for use in the species examined. Use of this system alleviated the need for multiple blood samples and the stress associated with obtaining those samples. This system may provide greater monitoring capabilities in patients with diabetes and promote the diagnostic and research potential of serial glucose monitoring in veterinary species.
Collapse
Affiliation(s)
- Charles E Wiedmeyer
- Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri 65211, USA.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Thiess S, Becskei C, Tomsa K, Lutz TA, Wanner M. Effects of high carbohydrate and high fat diet on plasma metabolite levels and on i.v. glucose tolerance test in intact and neutered male cats. J Feline Med Surg 2004; 6:207-18. [PMID: 15265476 DOI: 10.1016/j.jfms.2003.09.006] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 08/01/2003] [Accepted: 09/16/2003] [Indexed: 10/26/2022]
Abstract
To elucidate the impact of dietary influence on carbohydrate and lipid metabolism and on the development of diabetes mellitus in the carnivorous cat, a 3 weeks feeding trial was carried out on six sexually intact and six neutered adult male cats. The effects of two isonitrogenic diets, differing in carbohydrate and fat content, were investigated on plasma metabolite levels in a 24-h blood sampling trial. Plasma leptin concentrations were also determined at the beginning and at the end of the 24-h trial. Glucose and insulin response was measured in an i.v. glucose tolerance test. A 5 days long digestion trial was also performed, which revealed a high digestion capacity of both fat and carbohydrates in cats. The high fat diet induced a significant rise in the plasma triglyceride, FFA, beta-hydroxybutyrate and cholesterol concentration, while the elevation in the glucose level did not reach significance. In the glucose tolerance test no significant difference was found between the neutered and intact cats. However, independently of the sexual state, the cats on the high fat diet showed a slightly elongated glucose clearance and reduced acute insulin response to glucose administration. This is indicative of diminished pancreatic insulin secretion and/or beta-cell responsiveness to glucose. The results of this preliminary study may be the impetus for a long-term study to find out whether it is rather the fat rich ration than carbohydrate rich diet that is expected to impair glucose tolerance and thus might contribute to the development of diabetes mellitus in cats. Whether the alteration in glucose metabolism is due to altered leptin levels remains to be determined.
Collapse
Affiliation(s)
- S Thiess
- Institute of Animal Nutrition, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland
| | | | | | | | | |
Collapse
|
14
|
Wiedmeyer CE, Johnson PJ, Cohn LA, Meadows RL. Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc 2004; 223:987-92. [PMID: 14552487 DOI: 10.2460/javma.2003.223.987] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To evaluate a continuous glucose monitoring system (CGMS) for use in dogs, cats, and horses. DESIGN Prospective clinical study. Animals-7 horses, 3 cats, and 4 dogs that were clinically normal and 1 horse, 2 cats, and 3 dogs with diabetes mellitus. PROCEDURE Interstitial glucose concentrations were monitored and recorded every 5 minutes by use of a CGMS. Interstitial glucose concentrations were compared with whole blood glucose concentrations as determined by a point-of-care glucose meter. Interstitial glucose concentrations were also monitored in 2 clinically normal horses after oral and i.v. administration of glucose. RESULTS There was a positive correlation between interstitial and whole blood glucose concentrations for clinically normal dogs, cats, and horses and those with diabetes mellitus. Events such as feeding, glucose or insulin administration, restraint, and transport to the clinic were recorded by the owner or clinician and could be identified on the graph and associated with time of occurrence. CONCLUSIONS AND CLINICAL RELEVANCE Our data indicate that use of CGMS is valid for dogs, cats, and horses. This system alleviated the need for multiple blood samples and the stress associated with obtaining those samples. Because hospitalization was not required, information obtained from the CGMS provided a more accurate assessment of the animal's glucose concentrations for an extended period, compared with measurement of blood glucose concentrations. Use of the CGMS will promote the diagnostic and research potential of serial glucose monitoring.
Collapse
Affiliation(s)
- Charles E Wiedmeyer
- Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA
| | | | | | | |
Collapse
|
15
|
Casella M, Wess G, Hässig M, Reusch CE. Home monitoring of blood glucose concentration by owners of diabetic dogs. J Small Anim Pract 2003; 44:298-305. [PMID: 12866927 DOI: 10.1111/j.1748-5827.2003.tb00158.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The objective of this study was to investigate whether home monitoring of blood glucose of diabetic dogs by owners would be possible on a long-term basis. The owners of 12 diabetic dogs were each asked to generate four glucose curves by taking capillary blood samples from their dog's ear, at three- to four-week intervals. Within one week of each curve being produced by the owner, an additional curve was produced by a veterinarian in the hospital. Ten owners were able to generate blood glucose curves; three of them needed a second demonstration, and two telephoned for further guidance. The blood glucose concentrations obtained from the first two 'hospital' curves were significantly lower than those measured at home. Overall, in 42 per cent of cases, the treatment based on the hospital curves would have been different from that based on 'home' curves. The results of this study indicate that the majority of owners were able and willing to perform long-term monitoring of the blood glucose concentrations of their dogs.
Collapse
Affiliation(s)
- M Casella
- Clinic for Small Animal Internal Medicine, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland
| | | | | | | |
Collapse
|
16
|
Appleton DJ, Rand JS, Sunvold GD, Priest J. Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats. J Feline Med Surg 2002; 4:13-25. [PMID: 11869052 DOI: 10.1053/jfms.2001.0157] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The effect of dietary chromium supplementation on glucose and insulin metabolism in healthy, non-obese cats was evaluated. Thirty-two cats were randomly divided into four groups and fed experimental diets consisting of a standard diet with 0 ppb (control), 150 ppb, 300 ppb, or 600 ppb added chromium as chromium tripicolinate. Intravenous glucose tolerance, insulin tolerance and insulin sensitivity tests with minimal model analysis were performed before and after 6 weeks of feeding the test diets. During the glucose tolerance test, glucose concentrations, area under the glucose concentration-time curve, and glucose half-life (300 ppb only), were significantly lower after the trial in cats supplemented with 300 ppb and 600 ppb chromium, compared with values before the trial. Fasting glucose concentrations measured on a different day in the biochemistry profile were also significantly lower after supplementation with 600 ppb chromium. There were no significant differences in insulin concentrations or indices in either the glucose or insulin tolerance tests following chromium supplementation, nor were there any differences between groups before or after the dietary trial.Importantly, this study has shown a small but significant, dose-dependent improvement in glucose tolerance in healthy, non-obese cats supplemented with dietary chromium. Further long-term studies are warranted to determine if the addition of chromium to feline diets is advantageous. Cats most likely to benefit are those with glucose intolerance and insulin resistance from lack of exercise, obesity and old age. Healthy cats at risk of glucose intolerance and diabetes from underlying low insulin sensitivity or genetic factors may also benefit from long-term chromium supplementation.
Collapse
Affiliation(s)
- D J Appleton
- Companion Animal Sciences Department, School of Veterinary Science and Animal Production, The University of Queensland, St. Lucia, Brisbane, Qld, 4072, Australia
| | | | | | | |
Collapse
|
17
|
Appleton DJ, Rand JS, Priest J, Sunvold GD. Determination of reference values for glucose tolerance, insulin tolerance, and insulin sensitivity tests in clinically normal cats. Am J Vet Res 2001; 62:630-6. [PMID: 11327477 DOI: 10.2460/ajvr.2001.62.630] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To determine reference values and test variability for glucose tolerance tests (GTT), insulin tolerance tests (ITT), and insulin sensitivity tests (IST) in cats. ANIMALS 32 clinically normal cats. PROCEDURE GTT, ITT, and IST were performed on consecutive days. Tolerance intervals (ie, reference values) were calculated as means +/- 2.397 SD for plasma glucose and insulin concentrations, half-life of glucose (T1/2 glucose), rate constants for glucose disappearance (Kglucose and Kitt), and insulin sensitivity index (Si). Tests were repeated after 6 weeks in 8 cats to determine test variability. RESULTS Reference values for T1/2glucose, Kglucose, and fasting plasma glucose and insulin concentrations during GTT were 45 to 74 minutes, 0.93 to 1.54 %/min, 37 to 104 mg/dl, and 2.8 to 20.6 microU/ml, respectively. Mean values did not differ between the 2 tests. Coefficients of variation for T1/2glucose, Kglucose, and fasting plasma glucose and insulin concentrations were 20, 20, 11, and 23%, respectively. Reference values for Kitt were 1.14 to 7.3%/min, and for SI were 0.57 to 10.99 x 10(4) min/microU/ml. Mean values did not differ between the 2 tests performed 6 weeks apart. Coefficients of variation for Kitt and SI were 60 and 47%, respectively. CONCLUSIONS AND CLINICAL RELEVANCE GTT, ITT, and IST can be performed in cats, using standard protocols. Knowledge of reference values and test variability will enable researchers to better interpret test results for assessment of glucose tolerance, pancreatic beta-cell function, and insulin sensitivity in cats.
Collapse
Affiliation(s)
- D J Appleton
- Department of Clinical Animal Sciences, School of Veterinary Science and Animal Production, University of Queensland, St Lucia, Brisbane, Australia
| | | | | | | |
Collapse
|
18
|
Abstract
OBJECTIVE To evaluate the clinical and analytic accuracy of 5 portable blood glucose meters (PBGM) in cats, with emphasis on the detection of potential sources of error. ANIMALS 200 cats. PROCEDURE Venous blood glucose readings from 5 PBGM were compared with the results of a hexokinase reference method. Agreement among methods was determined by error grid analysis and statistical methods. RESULTS A total of 2,975 PBGM readings and 513 reference values were analyzed. The accuracy of the PBGM varied in different glycemic ranges. The largest differences between PBGM readings and reference values were in the high glycemic range; 4 PBGM underestimated and 1 PBGM overestimated the reference values in most instances. In the low and reference glycemic ranges, the absolute differences between PBGM readings and reference values were small. Despite the analytic differences in accuracy, 4 PBGM had 100% and 1 PBGM had 98.7% of readings in the clinically acceptable values of the error grid analysis. Within- and between-day precisions were good for all PBGM. Significant differences were not detected between readings of EDTA and lithium-heparinized blood and fresh blood without anticoagulant. Compared with these blood types, 1 PBGM had significantly different readings with fluoride anticoagulated blood. In blood samples with a low Hct, all PBGM overestimated glucose concentrations. Sample volumes < 3 microl resulted in inaccurate measurements in 3 PBGM. CONCLUSIONS AND CLINICAL RELEVANCE Performance varied among the 5 PBGM analyzed; however, all PBGM were deemed acceptable for clinical use in cats.
Collapse
Affiliation(s)
- G Wess
- Clinic for Small Animal Internal Medicine, University CH-8057 Zurich, Switzerland
| | | |
Collapse
|
19
|
Abstract
When treating diabetic cats, the primary aim is to control clinical signs without causing clinical hypoglycaemia. Secondary goals are to maximise the chances of attaining diabetic remission and to minimise the risk of complications due to chronic hyperglycaemia. A treatment plan that is convenient for the owner is important for compliance. Underweight or overweight diabetic cats should be fed with the aim of normalising bodyweight. Current evidence suggests that non-obese diabetic cats can be fed ad libitum. The oral hypoglycaemic drug glipizide is well established as a treatment for about a third of diabetic cats, which have residual beta cell function. Preliminary studies on other oral agents such as vanadium salts, metformin, and troglitazone indicate a potential use in some diabetic cats. Insulin treatment remains the treatment of choice for the majority of diabetic cats. Choice of insulin, dose rates and monitoring of treatment are discussed.
Collapse
Affiliation(s)
- G Martin
- Companion Animal Sciences, School of Veterinary Science and Animal Production, The University of Queensland, Australia 4072
| | | |
Collapse
|
20
|
Wess G, Reusch C. Capillary blood sampling from the ear of dogs and cats and use of portable meters to measure glucose concentration. J Small Anim Pract 2000; 41:60-6. [PMID: 10701188 DOI: 10.1111/j.1748-5827.2000.tb03164.x] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Two new methods for collection of capillary blood from the ear of dogs and cats for the measurement of blood glucose concentration using portable blood glucose meters (PBGMs) are described. The first method uses a lancing device after pre-warming the ear, while the second employs a vacuum lancing device. Both methods generated blood drops of adequate size, although the latter method was faster and easier to perform. Accuracy of the two PBGMs was evaluated clinically and statistically. Although assessment of statistical accuracy revealed differences between the PBGMs and the reference method, all of the PBGM readings were within clinically acceptable ranges. Measurement of capillary blood glucose concentration is easy to perform, inexpensive and fast. It may be used by owners to determine blood glucose concentrations at home, and could serve as a new tool for monitoring diabetic dogs and cats.
Collapse
Affiliation(s)
- G Wess
- Clinic for Small Animal Internal Medicine, University of Zürich, Switzerland
| | | |
Collapse
|
21
|
Abstract
OBJECTIVE To evaluate clinical and analytical accuracy of 5 portable blood glucose meters (PBGM) used to measure blood glucose concentrations in dogs and to determine potential sources of error. DESIGN Prospective study. ANIMALS 221 dogs. PROCEDURE Venous blood samples were obtained, and results of the 5 PBGM were compared with results of a hexokinase reference method. Agreement among methods was determined by use of error grid analysis and statistical methods. RESULTS Accuracy of the PBGM varied with glucose concentration of the sample. The largest differences between results of the PBGM and results of the reference method were obtained with samples with high glucose concentrations; 4 PBGM tended to underestimate and 1 PBGM tended to overestimate the true glucose concentration. Absolute differences between results of the PBGM and results of the reference method were small for samples with low glucose concentrations and samples with concentrations in the reference range. None of the PBGM yielded measurements that would result in clinically unacceptable errors. Within-run and between-day precision was good for all PBGM, and results were not affected by use of EDTA or heparin to anticoagulate blood. Readings of the PBGM were significantly higher for blood samples with low Hct than for samples with normal Hct. For 3 PBGM, samples < 3 microliters resulted in inaccurate measurements. CONCLUSIONS AND CLINICAL RELEVANCE Results suggest that currently available PBGM are sufficiently accurate for use in clinical practice to determine blood glucose concentrations in dogs.
Collapse
Affiliation(s)
- G Wess
- Clinic for Small Animal Internal Medicine, University of Zurich, Switzerland
| | | |
Collapse
|
22
|
Feldhahn JR, Rand JS, Kinnaird E. The effect of interday variation and a short-term stressor on insulin sensitivity in clinically normal cats. J Feline Med Surg 1999; 1:233-40. [PMID: 11714240 DOI: 10.1053/jfms.1999.0056] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
To determine whether there is a day-to-day variation in insulin sensitivity in cats, we subjected six clinically normal cats to four insulin-modified frequently sampled intravenous glucose tolerance tests (FSIVGTTs) over 7 days. The insulin-modified FSIVGTTs were analysed by the minimal model method. Minimal model insulin sensitivity (S(I)) averaged 2.9+/-0.4 x 10(-4) min(-1)/microU/ml (range 1.9-4.6 x 10(-4) min(-1)/microU/ml), with a mean interday coefficient of variation (CV) of 35.4+/-6.4% (range 12.8-58.5%). Glucose effectiveness (S(G)) averaged 0.029+/-0.002 min(-1)(range 0.024-0.037 min(-1)), and showed less interday variability with a mean CV of 24.7+/-4.3% (range 7.9-39.3%). Insulin sensitivity was also measured after a short-term stressor (5-min spray bath) of sufficient magnitude to elevate blood glucose levels. The mean insulin sensitivity after the stressor was 3.6+/-0.8 x 10(-4) min(-1)/microU/ml (range 1.6-7.3 x 10(-4) min(-1)/microU/ml), which was not significantly different to the mean insulin sensitivity before the short-term stressor (P=0.237). The mean glucose effectiveness after the stressor was 0.046+/-0.004 min(-1)(range 0.032-0.057 min(-1)), which was significantly different from mean glucose effectiveness before the short-term stressor (P=0.003). We conclude that insulin sensitivity is highly variable from day to day in normal cats, and that hyperglycaemia in response to short-term stressors is probably due to increased hepatic glucose production, rather than peripheral insulin resistance.
Collapse
Affiliation(s)
- J R Feldhahn
- Companion Animal Science, School of Veterinary Science and Animal Production, The University of Queensland, St Lucia 4072, Brisbane, Queensland, Australia
| | | | | |
Collapse
|
23
|
Martin GJ, Rand JS. Food intake and blood glucose in normal and diabetic cats fed ad libitum. J Feline Med Surg 1999; 1:241-51. [PMID: 11714241 DOI: 10.1053/jfms.1999.0052] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Ten diabetic cats were studied at intervals for up to 12 months with twice-daily insulin injections. Ten clinically healthy cats were also studied. Diets fed were based on the individual cat's performance, using mainly commercial dry or canned cat foods and fresh meat. In most cases more than one food was offered. Food was given fresh twice daily, and the cats allowed to eat ad libitum. The food intake and blood glucose were measured every 2 h in diabetic cats after insulin injection and in diabetic and normal cats without insulin injections. Food was quantified by the energy consumed (kJ ME), crude protein (g), crude fat (g), and carbohydrate (g). The blood glucose in 10 diabetic cats was measured for 2 h following a 20-min meal. Both diabetic cats and normal cats showed similar patterns of eating, with a higher food intake in the 2 h after fresh food was placed. Both groups of cats ate multiple small meals spread through the day and night. There was little or no correlation between the blood glucose and the amount of food consumed over the previous 2-h period, in insulin- or non-insulin-treated diabetic cats, or in normal cats. An overnight fast did not significantly alter morning blood glucose in diabetic cats. No demonstrable appetite stimulation occurred following an occurrence of low blood glucose; however, recorded incidences were few. No post-prandial hyperglycaemia was seen in the 10 diabetic cats during a 2-h period following the ingestion of typical cat foods.
Collapse
Affiliation(s)
- G J Martin
- Companion Animal Science, School of Veterinary Science and Animal Production, The University of Queensland, St Lucia 4072, Brisbane, Queensland, Australia
| | | |
Collapse
|
24
|
Abstract
Estimates of in vivo insulin sensitivity (S(I)) can be derived from minimal model analysis of a frequently sampled intravenous glucose tolerance test (FSIVGTT). Modification of the FSIVGTT by the injection of insulin allows insulin sensitivity to be measured in diabetics. To establish and compare reference values for insulin sensitivity in clinically normal and diabetic cats, we subjected 10 clinically normal cats and five diabetic cats to the insulin-modified FSIVGTT with minimal model analysis. Diabetic cats had a significantly lower insulin sensitivity than clinically normal cats (P<0.05). Mean insulin sensitivity in clinically normal cats was 3.22x10(-4)/min/microU/ml (range 1.71-5.23x10(-4)/min/microU/ml). In contrast, the mean insulin sensitivity in diabetic cats was 0.58x10(-4)/min/microU/ml (range 0.136-0.88x10(-4)/min/microU/ml), or approximately six times less insulin sensitive than clinically normal cats. Mean glucose effectiveness in clinically normal cats was 0.030/min (range 0.021-0.045/min). Mean glucose effectiveness in diabetic cats was 0.014/min (range 0.008-0.021/min). Our data demonstrate that insulin resistance is a feature of feline diabetes mellitus and that diabetic cats have a similar relative decrease in insulin sensitivity to humans with type 2 diabetes.
Collapse
Affiliation(s)
- J R Feldhahn
- Companion Animal Medicine and Surgery, School of Veterinary Science and Animal Production, The University of Queensland, St Lucia, Queensland, 4072, Australia
| | | | | |
Collapse
|
25
|
Martin GJ, Rand JS. Evaluation of a polyurethane jugular catheter in cats placed using a modified Seldinger technique. Aust Vet J 1999; 77:250-4. [PMID: 10330557 DOI: 10.1111/j.1751-0813.1999.tb11714.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To describe and evaluate the placement of a new design of polyurethane jugular catheter in cats using a modification of the technique of Seldinger. The maintenance and use of these catheters for repeated blood sampling over several days in healthy and diabetic cats is reported. PROCEDURE Thirty polyurethane jugular catheters were placed in 10 clinically healthy cats and 10 cats with diabetes mellitus using the modified Seldinger technique. Catheters were placed while the cats were under general anaesthesia. RESULTS The catheters remained in place for a range of 2 to 14 days (median 5 days) with no major complications. In all cats patency of the catheters was maintained until removal. All cats examined had patent jugular veins when assessed 4 or more weeks after the catheters were removed. CONCLUSIONS These polyurethane jugular catheters, when placed by a modified Seldinger technique, are effective and safe in cats, and jugular patency returns after the catheters are removed.
Collapse
Affiliation(s)
- G J Martin
- School of Veterinary Science, University of Queensland, St Lucia
| | | |
Collapse
|